cannabidiol 3% cream (AVCN583601)
/ Avicanna
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 03, 2020
The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial
(clinicaltrials.gov)
- P2/3; N=0; Withdrawn; Sponsor: Elena Pope
Clinical • New P2/3 trial • Pain
1 to 1
Of
1
Go to page
1